1 | inhibition | 13,815 |
2 | overexpression | 1,992 |
3 | upregulation | 1,164 |
4 | knockdown | 1,006 |
5 | up-regulation | 842 |
6 | down-regulation | 800 |
7 | downregulation | 732 |
8 | silencing | 614 |
9 | over-expression | 268 |
10 | overproduction | 246 |
11 | co-expression | 120 |
12 | colocalization | 87 |
13 | inhibitions | 77 |
14 | coexpression | 69 |
15 | co-localization | 67 |
16 | abrogation | 57 |
17 | knock-down | 51 |
18 | re-expression | 20 |
19 | co-application | 18 |
20 | uridylation | 16 |
21 | chemosuppression | 11 |
22 | glucosylation | 10 |
23 | suppressions | 10 |
24 | dimerisation | 9 |
25 | immunoneutralization | 9 |
26 | upregulations | 9 |
27 | co-overexpression | 8 |
28 | heat-inducibility | 8 |
29 | masculinization | 8 |
30 | r-isomer | 8 |
31 | down-modulation | 7 |
32 | invigoration | 7 |
33 | underexpression | 6 |
34 | up-regulations | 6 |
35 | alphavbeta3 | 5 |
36 | hypoacetylation | 5 |
37 | hypophosphorylation | 5 |
38 | minigenes | 5 |
39 | redecoration | 5 |
40 | superinduction | 5 |
41 | auto-phosphorylation | 4 |
42 | decoloration | 4 |
43 | fks1 | 4 |
44 | over-stimulation | 4 |
45 | ph-dependence | 4 |
46 | riskiness | 4 |
47 | toxification | 4 |
48 | trypsinization | 4 |
49 | auto-induction | 3 |
50 | autodigestion | 3 |
51 | cefrag | 3 |
52 | dephytinization | 3 |
53 | mesylation | 3 |
54 | mucunain | 3 |
55 | treat-ment | 3 |
56 | 2-halogenation | 2 |
57 | 3'-region | 2 |
58 | dynamicity | 2 |
59 | ethylation | 2 |
60 | genopsycho-somatotyping | 2 |
61 | over-encapsulation | 2 |
62 | photo-excitation | 2 |
63 | trans-sialidase | 2 |
64 | upregulators | 2 |
65 | 'web | 1 |
66 | 11.3g/l | 1 |
67 | 135.6mg/l | 1 |
68 | 20.7g/l | 1 |
69 | 3-acylation | 1 |
70 | 3-halogenation | 1 |
71 | back-interpolation | 1 |
72 | curve-effect | 1 |
73 | diacetylations | 1 |
74 | electroactivation | 1 |
75 | g12/13 | 1 |
76 | gsk3β-kd | 1 |
77 | immobillzation | 1 |
78 | monoaddition | 1 |
79 | n-arylation | 1 |
80 | nano-confinement | 1 |
81 | nanophotothermolisys | 1 |
82 | o-glycoforms | 1 |
83 | oligoadenylation | 1 |
84 | outpour | 1 |
85 | over-expansion | 1 |
86 | over-generation | 1 |
87 | overlap/exchange | 1 |
88 | pan-inhibitor | 1 |
89 | phorsphorylation | 1 |
90 | phoshorylation | 1 |
91 | phosphorylation/inhibition | 1 |
92 | photoluminescences | 1 |
93 | preceptions | 1 |
94 | re-formulation | 1 |
95 | recruitment/activation | 1 |
96 | release/accumulation | 1 |
97 | solution-blending | 1 |
98 | spiroannulation | 1 |
99 | β1-receptors | 1 |
1 | 'web | 1 |
2 | 11.3g/l | 1 |
3 | 135.6mg/l | 1 |
4 | 2-halogenation | 2 |
5 | 20.7g/l | 1 |
6 | 3'-region | 2 |
7 | 3-acylation | 1 |
8 | 3-halogenation | 1 |
9 | abrogation | 57 |
10 | alphavbeta3 | 5 |
11 | auto-induction | 3 |
12 | auto-phosphorylation | 4 |
13 | autodigestion | 3 |
14 | back-interpolation | 1 |
15 | cefrag | 3 |
16 | chemosuppression | 11 |
17 | co-application | 18 |
18 | co-expression | 120 |
19 | co-localization | 67 |
20 | co-overexpression | 8 |
21 | coexpression | 69 |
22 | colocalization | 87 |
23 | curve-effect | 1 |
24 | decoloration | 4 |
25 | dephytinization | 3 |
26 | diacetylations | 1 |
27 | dimerisation | 9 |
28 | down-modulation | 7 |
29 | down-regulation | 800 |
30 | downregulation | 732 |
31 | dynamicity | 2 |
32 | electroactivation | 1 |
33 | ethylation | 2 |
34 | fks1 | 4 |
35 | g12/13 | 1 |
36 | genopsycho-somatotyping | 2 |
37 | glucosylation | 10 |
38 | gsk3β-kd | 1 |
39 | heat-inducibility | 8 |
40 | hypoacetylation | 5 |
41 | hypophosphorylation | 5 |
42 | immobillzation | 1 |
43 | immunoneutralization | 9 |
44 | inhibition | 13,815 |
45 | inhibitions | 77 |
46 | invigoration | 7 |
47 | knock-down | 51 |
48 | knockdown | 1,006 |
49 | masculinization | 8 |
50 | mesylation | 3 |
51 | minigenes | 5 |
52 | monoaddition | 1 |
53 | mucunain | 3 |
54 | n-arylation | 1 |
55 | nano-confinement | 1 |
56 | nanophotothermolisys | 1 |
57 | o-glycoforms | 1 |
58 | oligoadenylation | 1 |
59 | outpour | 1 |
60 | over-encapsulation | 2 |
61 | over-expansion | 1 |
62 | over-expression | 268 |
63 | over-generation | 1 |
64 | over-stimulation | 4 |
65 | overexpression | 1,992 |
66 | overlap/exchange | 1 |
67 | overproduction | 246 |
68 | pan-inhibitor | 1 |
69 | ph-dependence | 4 |
70 | phorsphorylation | 1 |
71 | phoshorylation | 1 |
72 | phosphorylation/inhibition | 1 |
73 | photo-excitation | 2 |
74 | photoluminescences | 1 |
75 | preceptions | 1 |
76 | r-isomer | 8 |
77 | re-expression | 20 |
78 | re-formulation | 1 |
79 | recruitment/activation | 1 |
80 | redecoration | 5 |
81 | release/accumulation | 1 |
82 | riskiness | 4 |
83 | silencing | 614 |
84 | solution-blending | 1 |
85 | spiroannulation | 1 |
86 | superinduction | 5 |
87 | suppressions | 10 |
88 | toxification | 4 |
89 | trans-sialidase | 2 |
90 | treat-ment | 3 |
91 | trypsinization | 4 |
92 | underexpression | 6 |
93 | up-regulation | 842 |
94 | up-regulations | 6 |
95 | upregulation | 1,164 |
96 | upregulations | 9 |
97 | upregulators | 2 |
98 | uridylation | 16 |
99 | β1-receptors | 1 |
1 | fks1 | 4 |
2 | g12/13 | 1 |
3 | alphavbeta3 | 5 |
4 | 'web | 1 |
5 | gsk3β-kd | 1 |
6 | ph-dependence | 4 |
7 | overlap/exchange | 1 |
8 | trans-sialidase | 2 |
9 | cefrag | 3 |
10 | silencing | 614 |
11 | solution-blending | 1 |
12 | genopsycho-somatotyping | 2 |
13 | 11.3g/l | 1 |
14 | 20.7g/l | 1 |
15 | 135.6mg/l | 1 |
16 | mucunain | 3 |
17 | 3'-region | 2 |
18 | over-expansion | 1 |
19 | chemosuppression | 11 |
20 | re-expression | 20 |
21 | co-expression | 120 |
22 | over-expression | 268 |
23 | coexpression | 69 |
24 | underexpression | 6 |
25 | overexpression | 1,992 |
26 | co-overexpression | 8 |
27 | toxification | 4 |
28 | co-application | 18 |
29 | abrogation | 57 |
30 | back-interpolation | 1 |
31 | down-modulation | 7 |
32 | down-regulation | 800 |
33 | up-regulation | 842 |
34 | downregulation | 732 |
35 | upregulation | 1,164 |
36 | over-stimulation | 4 |
37 | re-formulation | 1 |
38 | release/accumulation | 1 |
39 | spiroannulation | 1 |
40 | over-encapsulation | 2 |
41 | 3-acylation | 1 |
42 | uridylation | 16 |
43 | ethylation | 2 |
44 | oligoadenylation | 1 |
45 | n-arylation | 1 |
46 | auto-phosphorylation | 4 |
47 | hypophosphorylation | 5 |
48 | phorsphorylation | 1 |
49 | phoshorylation | 1 |
50 | mesylation | 3 |
51 | glucosylation | 10 |
52 | hypoacetylation | 5 |
53 | 2-halogenation | 2 |
54 | 3-halogenation | 1 |
55 | over-generation | 1 |
56 | redecoration | 5 |
57 | invigoration | 7 |
58 | decoloration | 4 |
59 | dimerisation | 9 |
60 | photo-excitation | 2 |
61 | recruitment/activation | 1 |
62 | electroactivation | 1 |
63 | co-localization | 67 |
64 | colocalization | 87 |
65 | immunoneutralization | 9 |
66 | masculinization | 8 |
67 | trypsinization | 4 |
68 | dephytinization | 3 |
69 | immobillzation | 1 |
70 | auto-induction | 3 |
71 | superinduction | 5 |
72 | overproduction | 246 |
73 | inhibition | 13,815 |
74 | phosphorylation/inhibition | 1 |
75 | monoaddition | 1 |
76 | autodigestion | 3 |
77 | knock-down | 51 |
78 | knockdown | 1,006 |
79 | r-isomer | 8 |
80 | pan-inhibitor | 1 |
81 | outpour | 1 |
82 | photoluminescences | 1 |
83 | minigenes | 5 |
84 | o-glycoforms | 1 |
85 | suppressions | 10 |
86 | up-regulations | 6 |
87 | upregulations | 9 |
88 | diacetylations | 1 |
89 | inhibitions | 77 |
90 | preceptions | 1 |
91 | upregulators | 2 |
92 | β1-receptors | 1 |
93 | riskiness | 4 |
94 | nanophotothermolisys | 1 |
95 | curve-effect | 1 |
96 | treat-ment | 3 |
97 | nano-confinement | 1 |
98 | dynamicity | 2 |
99 | heat-inducibility | 8 |